Patent · US Active

Isothiazole derivatives as GPR120 agonists for the treatment of type II diabetes

US9067898B1 · kind B1 · utility

6Cited by

0References

20Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Carl R. Illig · Phoenixville, US
Mark R. Player · Phoenixville, US
Xuqing Zhang · Raritan, US

Key dates

Filing date	Mar 7, 2014
Grant date	Jun 30, 2015
Priority date	—
Expiry date	Mar 7, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR120 receptor. Such compounds are represented by Formula (I) as follows:wherein R1, G, and Q are defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.